Richard Steinhart
Financieel Directeur/CFO bij BIOXCEL THERAPEUTICS, INC.
Vermogen: 12 487 $ op 31-05-2024
Actieve functies van Richard Steinhart
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 08-11-2013 | - |
| Independent Dir/Board Member | 08-11-2013 | - | |
| ATOSSA THERAPEUTICS, INC. | Directeur/Bestuurslid | 03-03-2014 | - |
| Independent Dir/Board Member | 01-03-2014 | - | |
| BIOXCEL THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01-10-2017 | - |
| Financieel Directeur/CFO | 01-10-2017 | - |
Loopbaan van Richard Steinhart
Eerdere bekende functies van Richard Steinhart
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Remedy Pharmaceuticals, Inc.
 Remedy Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Remedy Pharmaceuticals, Inc. develops and commercializes pharmaceutical ingridients. It focuses on small molecule drugs for acute central nervous system disorders. The company was founded by David M. Geliebter and Sven M. Jacobson in 2004 and is headquartered in New York, NY. | Financieel Directeur/CFO | 14-10-2015 | 01-04-2017 |
| STRATA SKIN SCIENCES, INC. | Financieel Directeur/CFO | 24-04-2006 | 31-12-2013 |
| Bedrijfssecretaris | 24-04-2006 | 31-12-2013 | |
| Treasurer | 24-04-2006 | 31-12-2013 | |
| TG THERAPEUTICS, INC. | Directeur/Bestuurslid | 01-07-2004 | 01-01-2012 |
| Independent Dir/Board Member | 27-06-2011 | 01-01-2012 | |
| Forest Street Capital, LLC | Corporate Officer/Principal | 01-05-1992 | 24-04-2006 |
| EMISPHERE TECHNOLOGIES, INC. | Financieel Directeur/CFO | 01-05-1991 | 01-05-1992 |
CW Group, Inc.
 CW Group, Inc. Investment ManagersFinance CW Group Inc. (CW Group) is a venture capital firm founded in 1982. The firm is headquartered in New York. | Financieel Directeur/CFO | 01-01-1991 | 02-01-1992 |
| ░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░ ░░░░░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - | - |
Opleiding van Richard Steinhart
| Pace University | Masters Business Admin |
Statistieken
Internationaal
| Verenigde Staten | 13 |
Operationeel
| Director of Finance/CFO | 6 |
| Director/Board Member | 3 |
| Independent Dir/Board Member | 3 |
Sectoraal
| Health Technology | 8 |
| Finance | 2 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 5 |
|---|---|
| TG THERAPEUTICS, INC. | Health Technology |
| STRATA SKIN SCIENCES, INC. | Health Technology |
| ACTINIUM PHARMACEUTICALS, INC. | Health Technology |
| ATOSSA THERAPEUTICS, INC. | Health Technology |
| BIOXCEL THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 6 |
|---|---|
Emisphere Technologies, Inc.
 Emisphere Technologies, Inc. Pharmaceuticals: MajorHealth Technology Emisphere Technologies, Inc. is a commercial stage specialty pharmaceutical company, which engages in the development of new formulations of existing products and chemical entities, using Eligen Technology. Its product pipelines include eligen B12, eligen12.com, eligen B12 information, and purchase eligen B12. The company was founded in 1986 and is headquartered in Roseland, NJ. | Health Technology |
CW Group, Inc.
CW Group, Inc. Investment ManagersFinance CW Group Inc. (CW Group) is a venture capital firm founded in 1982. The firm is headquartered in New York. | Finance |
Remedy Pharmaceuticals, Inc.
Remedy Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Remedy Pharmaceuticals, Inc. develops and commercializes pharmaceutical ingridients. It focuses on small molecule drugs for acute central nervous system disorders. The company was founded by David M. Geliebter and Sven M. Jacobson in 2004 and is headquartered in New York, NY. | Health Technology |
| Forest Street Capital, LLC | |
| SAE Ventures | |
| MELA Sciences Inc. |
- Beurs
- Insiders
- Richard Steinhart
- Ervaring
